l-3,4-Dihydroxy-phenylalanine (l-DOPA) is the
most effective drug for the treatment of Parkinson’s disease,
which plays a very important role in clinical and neurochemistry.
However, how to achieve high-sensitivity recognition of l-DOPA still faces challenges. Here, a facile strategy is presented
to construct nitrogen-doped chiral CuO/CoO nanofibers (N-CuO/CoO NFs)
with nanozyme activity and electrochemiluminescence property, in which
CuO/CoO NFs are used as the catalytic activity center and chiral cysteine
(Cys) is used as the inducer of chiral recognition, for enantioselective
catalysis and sensitive recognition of DOPA enantiomers. Notably,
N doping not only enhances the enzyme-mimic activity of CuO/CoO NFs
but also amplifies their electrochemiluminescence (ECL) signals in
the presence of luminol. More importantly, in the presence of DOPA
enantiomers, the d-cysteine (d-Cys)-modified N-CuO/CoO
NFs exhibit different ECL performances; thus, d-Cys@N-CuO/CoO
NFs could selectively distinguish and sensitively detect l-DOPA through ECL signals, and the detection limit is 0.29 nM for l-DOPA. In addition, it also showed good sensing performance
for the determination of l-DOPA in fetal bovine serum. This
is the first report on the detection of DOPA enantiomers based on
an enhanced ECL strategy, providing a robust pathway for chiral discrimination
and detection of chiral molecules.